Update on Acute Bone and Joint Infections in Paediatrics: A Narrative Review on the Most Recent Evidence-Based Recommendations and Appropriate Antinfective Therapy
Open Access
- 6 August 2020
- journal article
- review article
- Published by MDPI AG in Antibiotics
- Vol. 9 (8) , 486
Abstract
Acute bone and joint infections (BJIs) in children may clinically occur as osteomyelitis (OM) or septic arthritis (SA). In clinical practice, one-third of cases present a combination of both conditions. BJIs are usually caused by the haematogenous dissemination of septic emboli carried to the terminal blood vessels of bone and joints from distant infectious processes during transient bacteraemia. Early diagnosis is the cornerstone for the successful management of BJI, but it is still a challenge for paediatricians, particularly due to its nonspecific clinical presentation and to the poor specificity of the laboratory and imaging first-line tests that are available in emergency departments. Moreover, microbiological diagnosis is often difficult to achieve with common blood cultures, and further investigations require invasive procedures. The aim of this narrative review is to provide the most recent evidence-based recommendations on appropriate antinfective therapy in BJI in children. We conducted a review of recent literature by examining the MEDLINE (Medical Literature Analysis and Retrieval System Online) database using the search engines PubMed and Google Scholar. The keywords used were “osteomyelitis”, OR “bone infection”, OR “septic arthritis”, AND “p(a)ediatric” OR “children”. When BJI diagnosis is clinically suspected or radiologically confirmed, empiric antibiotic therapy should be started as soon as possible. The choice of empiric antimicrobial therapy is based on the most likely causative pathogens according to patient age, immunisation status, underlying disease, and other clinical and epidemiological considerations, including the local prevalence of virulent pathogens, antibiotic bioavailability and bone penetration. Empiric antibiotic treatment consists of a short intravenous cycle based on anti-staphylococcal penicillin or a cephalosporin in children aged over 3 months with the addition of gentamicin in infants aged under 3 months. An oral regimen may be an option depending on the bioavailability of antibiotic chosen and clinical and laboratory data. Strict clinical and laboratory follow-up should be scheduled for the following 3–5 weeks. Further studies on the optimal therapeutic approach are needed in order to understand the best first-line regimen, the utility of biomarkers for the definition of therapy duration and treatment of complications.Keywords
This publication has 77 references indexed in Scilit:
- Prospective survey of acute osteoarticular infections in a French paediatric orthopedic surgery unitClinical Microbiology and Infection, 2013
- Systematic review of duration and choice of systemic antibiotic therapy for acute haematogenous bacterial osteomyelitis in childrenJournal of Paediatrics and Child Health, 2013
- Haematogenous acute and subacute paediatric osteomyelitisThe Journal of Bone and Joint Surgery. British volume, 2012
- Radionuclide Imaging in the Diagnosis and Management of Orthopaedic DiseaseJournal of the American Academy of Orthopaedic Surgeons, 2012
- Spinal infections in children: a reviewInternational Orthopaedics, 2011
- Short- Versus Long-term Antimicrobial Treatment for Acute Hematogenous Osteomyelitis of ChildhoodThe Pediatric Infectious Disease Journal, 2010
- Management of acute hematogenous osteomyelitis in childrenExpert Review of Anti-infective Therapy, 2010
- Sensitivity of Erythrocyte Sedimentation Rate and C-reactive Protein in Childhood Bone and Joint InfectionsClinical Orthopaedics and Related Research, 2009
- Use of Blood Culture Vials and Nucleic Acid Amplification for the Diagnosis of Pediatric Septic ArthritisClinical Infectious Diseases, 2008
- Infective Pyomyositis and Myositis in Children in the Era of Community‐Acquired, Methicillin‐ResistantStaphylococcus aureusInfectionClinical Infectious Diseases, 2006